• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential

tetano

Editor, Senior Moderator
Front Immunol


. 2023 Mar 15;14:1129190.
doi: 10.3389/fimmu.2023.1129190. eCollection 2023.
Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential


Gerasimos Eleftheriotis[SUP] 1 [/SUP], Efthymios P Tsounis[SUP] 2 [/SUP], Ioanna Aggeletopoulou[SUP] 2 3 [/SUP], Periklis Dousdampanis[SUP] 4 [/SUP], Christos Triantos[SUP] 2 [/SUP], Athanasia Mouzaki[SUP] 3 [/SUP], Markos Marangos[SUP] 1 [/SUP], Stelios F Assimakopoulos[SUP] 1 [/SUP]



Affiliations

Abstract

Although coronavirus disease 2019 (COVID-19) is primarily associated with mild respiratory symptoms, a subset of patients may develop more complicated disease with systemic complications and multiple organ injury. The gastrointestinal tract may be directly infected by SARS-CoV-2 or secondarily affected by viremia and the release of inflammatory mediators that cause viral entry from the respiratory epithelium. Impaired intestinal barrier function in SARS-CoV-2 infection is a key factor leading to excessive microbial and endotoxin translocation, which triggers a strong systemic immune response and leads to the development of viral sepsis syndrome with severe sequelae. Multiple components of the gut immune system are affected, resulting in a diminished or dysfunctional gut immunological barrier. Antiviral peptides, inflammatory mediators, immune cell chemotaxis, and secretory immunoglobulins are important parameters that are negatively affected in SARS-CoV-2 infection. Mucosal CD4+ and CD8+ T cells, Th17 cells, neutrophils, dendritic cells, and macrophages are activated, and the number of regulatory T cells decreases, promoting an overactivated immune response with increased expression of type I and III interferons and other proinflammatory cytokines. The changes in the immunologic barrier could be promoted in part by a dysbiotic gut microbiota, through commensal-derived signals and metabolites. On the other hand, the proinflammatory intestinal environment could further compromise the integrity of the intestinal epithelium by promoting enterocyte apoptosis and disruption of tight junctions. This review summarizes the changes in the gut immunological barrier during SARS-CoV-2 infection and their prognostic potential.

Keywords: COVID-19; cytokine storm; cytokines; defensins; gut barrier; interferon; microbiome.
 
Back
Top Bottom